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Aims Acute myocardial infarction (MI) is the leading cause of mortality worldwide. Anti-inflammatory strategies to reduce
neutrophil-driven acute post-MI injury have been shown to limit acute cardiac tissue damage. On the other hand,
whether neutrophils are required for resolving post-MI inflammation and repair is unknown.
Methods
and results
We show that neutrophil-depleted mice subjected to MI had worsened cardiac function, increased fibrosis, and pro-
gressively developed heart failure. Flow cytometry of blood, lymphoid organs and digested hearts revealed reduced
numbers of Ly6Chigh monocytes in infarcts of neutrophil-depleted mice, whereas the number of macrophages in-
creased, which was paralleled by reduced splenic Ly6Chigh monocyte mobilization but enhanced proliferation of cardiac
macrophages. Macrophage subtype analysis revealed reduced cardiac expression of M1 markers, whereas M2 markers
were increased in neutrophil-depleted mice. Surprisingly, we found reduced expression of phagocytosis receptor mye-
loid-epithelial-reproductive tyrosine kinase, a marker of reparative M2c macrophages which mediate clearance of apop-
totic cells. In agreement with this finding, neutrophil-depleted mice had increased numbers of TUNEL-positive cells
within infarcts. We identified neutrophil gelatinase-associated lipocalin (NGAL) in the neutrophil secretome as a
key inducer of macrophages with high capacity to engulf apoptotic cells. The cardiac macrophage phenotype in neutro-
phil-depleted mice was restored by administration of neutrophil secretome or NGAL.
Conclusion Neutrophils are crucially involved in cardiac repair after MI by polarizing macrophages towards a reparative phenotype.
Therapeutic strategies to reduce acute neutrophil-driven inflammation after MI should be carefully balanced as they
might interfere with the healing response and cardiac remodelling.
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Translational perspective
Neutrophils are generally considered to play a detrimental role after post-myocardial infarction (MI) revascularization, but their role in
myocardial ischaemia by itself has not been fully elucidated. Here, we provide novel evidence that neutrophils, despite being short-living
innate immune responders, could contribute to improve cardiac healing and outcomes by influencing macrophage polarization towards a
‘reparative’ phenotype, via neutrophil gelatinase-associated lipocalin release. A better knowledge of the role of neutrophils in MI healing
could help predicting the net results of neutrophil-targeted therapies in MI.
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Myocardial infarction (MI) induces an inflammatory response which is
required for the induction of cardiac repair processes. Various cell
types, including neutrophils and macrophages, are involved at different
stages of infarct healing, ultimately leading to scar formation and adap-
tive remodelling to preserve cardiac function.1 Attracted by cell debris,
danger-associated molecular patterns and cytokines of activated
neighbouring cells, neutrophils massively infiltrate the infarct area in
the first few hours following onset of ischemia.1 They generate high
levels of reactive oxygen species and secrete proteases, which exacer-
bates local vascular and tissue injury.2 Subsequently, monocyte-
derived macrophages are recruited to the heart to remove debris
and apoptotic neutrophils, which leads to activation of reparative path-
ways necessary for scar formation.1,3 Macrophages in the ischaemic
myocardium exhibit high plasticity and are involved in both inflamma-
tory as well as reparative processes. In the context of post-MI inflam-
mation resolution, pro-inflammatory M1 macrophages are thought to
undergo local conversion to M2 resolution–mediating macrophages.4
The crucial importance for efficient clearance of cell debris in re-
solving post-MI inflammation has been highlighted in mice with genet-
ic deficiency of myeloid-epithelial-reproductive tyrosine kinase
(MertK). Insufficient clearance of apoptotic cells by MertK-deficient
macrophages led to delayed inflammation resolution after MI, adverse
remodelling, and decreased cardiac function.5 Hence, reprogramming
macrophages in the heart to a reparative state seems to be an attract-
ive therapeutic strategy to improve infarct repair, e.g. as previously re-
ported by systemic administration of phosphatidylserine-decorated
liposomes.6 In this regard, further studies are warranted to better
understand the signalling pathways and local regulators in the cardiac
microenvironment promoting resolution of inflammation and macro-
phage differentiation to a reparative phenotype.
Less is known about the role of neutrophils in post-MI healing.
High neutrophil counts are considered as predictor of adverse clin-
ical outcomes and mortality in patients with acute coronary syn-
dromes,7,8 and their contribution in the acute inflammatory phase
after MI is generally considered detrimental. However, in acute in-
flammation, neutrophils are not only vital for the clearance of patho-
gens or debris, but also for the resolution of inflammation and
return to tissue homeostasis.9 Macrophages engulfing apoptotic
neutrophils activate an anti-inflammatory response by inhibiting
pro-inflammatory cytokines and inducing the production of
interleukin (IL)-10, transforming growth factor (TGF)-b and
pro-resolving lipid mediators.10 Consequently, anti-inflammatory
strategies reducing neutrophil influx in order to limit acute post-
ischaemic tissue injury might also inhibit the subsequent healing
response. In the present study, we therefore aimed to clarify the
contribution of neutrophils in post-MI healing.
Methods
An expanded version is provided in Supplementary material online,
Methods.
Animal experiments
Female 10- to 12-week-old C57BL/6J mice were used in this study. Myo-
cardial infarction was induced by permanent ligation of the left anterior
descending coronary artery (LAD). In additional experiments, mice
were subjected to transient LAD occlusion for 45 min followed by re-
perfusion. Neutrophil depletion was performed by intraperitoneal (i.p.)
injection of monoclonal antibody clone 1A8 (50 mg; Figure 1A). Control
mice received corresponding isotype i.p. injections. In some experi-
ments, mice received intramyocardial injections of neutrophil super-
natant in the ischaemic LAD territory.11 Control animals received
intramyocardial injections of vehicle (saline). In other experiments, re-
combinant murine neutrophil gelatinase-associated lipocalin (NGAL)
(100 mg) or vehicle (saline) was injected i.p. after 1, 3, and 4 days
LAD ligation. We performed echocardiography, quantification of infarct
size, histology, flow cytometry, real-time PCR, western blot, multiplex,
and ELISA as described in Supplementary material online. All animal
experiments were approved by the local ethical committee.
Macrophage polarization
Murine bone marrow-derived macrophages (BMM) were left untreated
or converted to M1 macrophages by stimulation with IFN-g (10 ng/mL
for 72 h). M2a or M2c were obtained by a 72 h treatment with IL-4
(20 ng/mL) or dexamethasone (20 nM), respectively. To assess the ef-
fect of neutrophil secretome or recombinant proteins on macrophage
polarizaton, BMM were polarized in the presence of 100 mL of neutro-
phil supernatant or with recombinant mouse NGAL (100 ng/mL), lacto-
ferrin (10 mg/mL), Cramp (1 mg/mL), neutrophil elastase (5 mM), or
myeloperoxidase (MPO, 5 mM). Human monocytes were isolated
from blood of healthy donors and macrophages were differentiated
from monocytes by culturing for 6 days in the presence of recombinant
human macrophage colony-stimulating factor (50 ng/mL). Human
macrophages were polarized as described above.
Western blot
MertK in heart or cell lysates was detected with anti-MertK antibody




Protein G-conjugated magnetic beads were incubated with goat poly-
clonal anti-NGAL antibody (R&D Systems) or normal goat IgG as nega-
tive control. The antibody-conjugated beads were incubated with
500 mL of conditioned medium obtained from activated mouse neutro-
phils, magnetically separated and supernatants collected for subsequent
treatment of macrophages.
Efferocytosis
Macrophages were co-cultured with apoptotic mouse cardiomyocytes
(stained with calcein AM) at 378C for 60 min. Phagocytosis efficiency
(%) was quantified by flow cytometry and calculated as calcein positive
divided by the total number of macrophages.
Statistical analysis
All data are expressed as mean+ SD, and statistical analysis was per-
formed with Prism Software (version 6; GraphPad, CA, USA). Endpoint
comparisons between 2 groups were performed using unpaired 2-tailed
Student’s t-test. For multiple comparisons, false discovery rate accord-
ing to Benjamini–Hochberg was applied to control type I false positive
errors, and FDR was set to 0.05. For parallel repeated-measures studies,
2-way ANOVA was used with Bonferroni post hoc evaluation to deter-
mine the significance for individual time points. A 2-tailed P , 0.05 was
considered as significant.










Neutrophil depletion worsens cardiac
function and promotes heart failure
Depletion with anti-Ly6G resulted in significant reduction of circu-
lating neutrophil counts, whereas blood monocytes were unaffected
at steady state (Supplementary material online, Figure S1). In agree-
ment with previous observations after prolonged ischaemia,12 we
found no difference in infarct size between control and neutrophil-
depleted mice 24 h post-infarction (Figure 1B). However, 7–14 days
after infarction, neutrophil depletion led to worsening of heart func-
tion. Characteristic features of neutrophil depletion were larger
end-systolic left ventricular dimensions, a significant reduction of
left ventricular ejection fraction and cardiac output (Figure 1C–H
and Supplementary material online, Table S1).
In support of reduced global contractility, infarcted hearts of
neutrophil-depleted mice had pronounced hypokinesia of left ven-
tricular walls (Figure 1I). The radial strain was significantly more de-
creased in infarcted hearts of depleted animals compared with
controls (Figure 1J and K ). Worsening of global contractility might
lead to heart failure (HF). In support of this hypothesis, neutrophil-
depleted mice had up-regulated cytokine and chemokine levels as-
sociated with HF13– 15 7 days post-MI (Figure 2A–F). Moreover, the
kidneys had macroscopic lesions and increased expression of
galectin-3, a marker of kidney injury (Figure 2G and H )16 as well as
increased plasma levels of creatinine (Figure 2I).
Neutrophil depletion promotes excessive
fibrosis
Histological analysis of the myocardium revealed an increased
percentage of a-smooth muscle actin-positive myofibroblasts
7 days post-MI in neutrophil-depleted mice (Figure 3A and B), which
was confirmed at the mRNA level (Figure 3C). The number of
CD31-stained microvessels in healing infarcts of control and
neutrophil-depleted mice was comparable (Figure 3D). Consistent
with a higher amount of cells promoting fibrosis, the collagen con-
tent, in particular of thicker type I collagen fibres, was higher in in-
farcts of depleted mice (Figure 3E–H). These findings suggest that
depletion of neutrophils leads to excessive fibrosis that might
explain the progressive worsening of cardiac function.
Figure 1 Neutrophil depletion does not affect infarct size but progressively worsens cardiac function. (A) Experimental protocol for treatment
with neutrophil-depleting antibody (Ly6G) or isotype. (B) Quantification of ratios between infarct size (myocardial infarction), area at risk, and left
ventricular area, 24 h after myocardial infarction. (C–H ) Quantification of functional parameters after sham operation (Day 0) or 3, 7, 14 days after
myocardial infarction. (I ) Vector diagrams showing the direction and magnitude of myocardial contraction at midsystole. Three-dimensional
regional wall displacement illustrations, showing contraction (positive values, yellow–red) or relaxation (negative values, blue) of consecutive
cardiac cycle results. (J ) Global averages of radial strain and (K) measurement of the area under the curve of radial strain. Data are mean+ SD
from 8 mice/group.
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Neutrophil depletion modulates cardiac
monocyte und macrophage profiles
Unfavourable repair in the absence of neutrophils might be a
consequence of impaired resolution of inflammation due to insuffi-
cient monocyte recruitment or activation of reparative macro-
phages. We therefore analysed leucocyte profiles in hearts and
lymphoid organs. As expected, treatment with depleting antibody
Ly6G potently reduced cardiac neutrophil counts (Figure 4A
and B). We detected an overall reduction of blood leukocytes in
neutrophil-depleted mice up to 7 days after MI (Supplementary ma-
terial online, Figure S1), probably due to reduced neutrophil-
mediated inflammation. Flow cytometric analysis of digested hearts
revealed less Ly6Chi monocytes 3 days post-infarction, whereas the
number of macrophages was increased at day 3 to 7 post-infarction
(Figure 4C and D).
In response to MI, monocytes are mobilized from the bone mar-
row and spleen into the blood stream and subsequently recruited
into the ischaemic myocardium.17 In agreement with reduced re-
cruitment of monocytes into infarcts of neutrophil-depleted mice,
Figure 2 Neutrophil depletion leads to up-regulation of markers for heart failure. (A–C) Quantification of cardiac mRNA expression in isotype-
treated and neutrophil-depleted (Ly6G) mice 7 days after myocardial infarction. (D–F) Plasma levels 7 days after MI. (G) Macroscopic view of the
kidney 5 days after myocardial infarction. Arrows indicate macroscopic lesions observed in neutrophil-depleted mice. (H ) Representative
galectin-3 immunostaining 5 days after myocardial infarction. (I ) Plasma creatinine levels before and 1, 3, 7, 14 days post-myocardial infarction.
Data are mean+ SD from 3–4 mice/group.
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the spleens contained higher numbers of the Ly6Chi subset
(Figure 4E). The bone marrow mobilization of monocytes was not
different between depleted and control group (data not shown).
In support of reduced splenic monocyte mobilization, we found de-
creased plasma levels of chemokines involved in monocyte recruit-
ment1,18 one day post-MI (Figure 4F).
Neutrophil depletion promotes local
macrophage proliferation
To explain the increased number of macrophages in the heart, we
may speculate that the microenvironment in the absence of
neutrophil-driven inflammation supports an expansion by local
proliferation. In support of this hypothesis, we found decreased
plasma levels of pro-inflammatory cytokine levels IL-1b, IL-12,
TNF-a, and IFN-g in neutrophil-depleted mice (Figure 4G). Con-
versely, plasma levels of IL-4, a cytokine that induces macrophage
proliferation and M2 polarization,19,20 were increased (Figure 4H).
Moreover, the flow cytometric analysis revealed a higher number
of proliferating macrophages, evidenced by higher percentage of
KI-67-positive macrophages in G1 and G2/S/M phase, whereas
the percentage in G0 decreased in infarcted hearts of neutrophil-
depleted mice (Figure 4I and J ). Conversely, we determined a lower
percentage of monocytes in G1 with concomitant increase of
monocytes in the G0 phase (Figure 4K). Therefore, our data suggest
that neutrophils are crucial regulators of the microenvironment
driving polarization and proliferation of macrophages involved in
cardiac repair.
Figure 3 Neutrophil depletion increases cardiac fibrosis. (A) Myofibroblasts within infarct areas identified by a-smooth muscle actin labelling
(green) and 4′,6-diamidino-2-phenylindole staining of nuclei (blue) in hearts from neutrophil-depleted (Ly6G) or isotype-treated mice. Scale bar,
50 mm; ×20 magnification. (B) Quantification of a-smooth muscle actin staining as ratio between stained and total area of myocardium within
randomly selected fields. (C) Quantification of a-smooth muscle actin mRNA levels, represented as fold change compared with sham-operated
hearts. (D) Quantification of CD31-stained microvessels within infarct areas of randomly selected fields. (E and G) Representative collagen staining
with Sirius red and Masson trichome (collagen in blue) at day 7 after infarction. Images were taken at ×2.5 magnification (whole hearts, Sirius red)
and ×20 magnification of infarct area and remote zone (scale bar, 100 mm). (F) Quantification of fibrosis as ratio between collagen-stained area
and total area of the left ventricle (LV). (H ) Relative content of type I and III collagen fibres within infarcts. The graphs show mean+ SD from 5
mice/group.
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Figure 4 Neutrophil depletion modulates cardiac monocyte/macrophage profiles, splenic mobilization, and local proliferation. (A–D) Repre-
sentative FACS plots and quantification of neutrophils, Ly6Chigh monocytes and macrophages in digested hearts of neutrophil-depleted (Ly6G) or
isotype-treated mice at baseline (0) or 1–7 days after myocardial infarction. (E) Quantification of Ly6Chigh monocytes in the spleen. (F ) Plasma
levels of chemokines involved in monocyte recruitment 24 h after myocardial infarction. Plasma levels of (G) pro- and (H ) anti-inflammatory cy-
tokines 24 h after MI. (I–K) Quantification of proliferating (KI67 positive) Ly6Chigh monocytes and macrophages in the heart 3 days after myo-
cardial infarction, based on flow cytometric cell cycle analysis using 7-AAD for nuclear DNA staining. (I ) Representative dot plots with quadrants
to identify cells in G0 (lower left), G1 (upper left), and G2/S/M (upper right) phase. (L) Quantification of Ly6Chigh monocytes and macrophages in
the heart 3 days after myocardial infarction with or without intramyocardial injection of neutrophil supernatant. (M) Cardiac mRNA expression
levels of M1 and M2 markers, normalized to hypoxanthine phosphoribosyltransferase (fold change compared with isotype group, P , 0.05 for all
represented factors). (B–H) Data are mean+ SD from 8 (J and K ) 5 or (L and M) 3 mice/group.
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The neutrophil secretome changes
cardiac monocyte and macrophage
profiles
To strengthen this finding, we asked whether neutrophil super-
natant was sufficient to restore the cardiac macrophage profile. In-
deed, local administration of neutrophil supernatant into infarcted
hearts of neutrophil-depleted mice partially reversed the phenotype
by increasing the number of Ly6Chi monocytes, while macrophage
numbers decreased (Figure 4L).
Neutrophil depletion affects macrophage
polarization
Polarized macrophages are generally referred to as M1 and M2
macrophages.21 M1 macrophages are found in the early stages after
MI injury and play a key role in acute inflammation, followed by rep-
arative M2 macrophages that mediate resolution of inflammation.4
We characterized the transcriptional profile in Ly6G depleted vs.
control hearts 7 days post-MI and found a significant down-
regulation of M1 markers (IL-12, TNFa, IFNg, IP-10, IL1b) and up-
regulation of M2 signature markers (CX3CR1, arginase, YM1, IL-4)
compared with controls (Figure 4M). Surprisingly, expression of
macrophage marker MertK, a phagocytosis receptor mainly ex-
pressed by M2c macrophages,22,23 was decreased (Figure 4M).
The neutrophil secretome promotes
macrophage polarization towards M2c
We hypothesized that factors released by neutrophils might pro-
mote an M2c phenotype with enhanced ability to phagocyte dead
cardiomyocytes. To verify this possibility, we tested the influence
of neutrophil supernatant on murine macrophage polarization.
We confirmed that MertK was mainly expressed by in vitro polarized
M2c macrophages, whereas M1 and M2a macrophages expressed
only low levels of MertK (Figure 5A and B). Addition of neutrophil
supernatant induced MertK expression in M2a macrophages, indi-
cating a polarization from M2a toward M2c (Figure 5A and B). To
test a potential relevance for humans, we incubated human primary
macrophages with human neutrophil supernatant and found a com-
parable induction of MertK expression in M2a polarized macro-
phages (Figure 5C and D).
Neutrophil-derived neutrophil
gelatinase-associated lipocalin promotes
macrophage polarization towards M2c
We further screened the effect of various recombinant neutrophil-
related proteins on macrophage polarization. Strikingly, the effect of
neutrophil supernatant on MertK expression was reproduced by in-
cubating in vitro polarized murine macrophages with recombinant
NGAL (Figure 5A and B). To validate this finding, we performed im-
munodepletion of NGAL in neutrophil supernatant, which blunted
the M2c-polarizing effect (Figure 5A and B). No change in macro-
phage polarization from M2a to M2c was observed when cells
were treated with other neutrophil-released proteins, i.e. recom-
binant Cramp, lactoferrin, neutrophil elastase, or MPO (Supplemen-
tary material online, Figure S2).
In agreement with our in vitro data, we found reduced cardiac
protein levels of the M2c marker MertK in hearts of neutrophil-
depleted mice (Figure 5E and F ). Neutrophil gelatinase-associated
lipocalin plasma levels were up-regulated 1–3 days after MI, but
were significantly lower in neutrophil-depleted mice (Figure 5G),
indicating neutrophils to be an important source for NGAL
expression after MI. Systemic administration of NGAL in neutrophil-
depleted mice not only restored normal plasma levels (Supplemen-
tary material online, Figure S4) but also cardiac protein levels of
MertK (Figure 5E and F ). This effect was confirmed by flow cyto-
metric analysis of digested hearts, revealing a lower percentage of
MertKhi expressing macrophages in neutrophil-depleted hearts,
while their percentage was restored when injecting NGAL
(Figure 5H and I ).
M2c polarization is required for apoptotic
cell clearance
An important role of M2c macrophages is the clearance of apoptotic
cells (efferocytosis),22 which is of crucial importance for wound
healing after MI.5 To assess the role of neutrophil-derived NGAL
on efferocytosis capacity, we treated in vitro polarized macrophages
with neutrophil supernatant or NGAL. After incubation with apop-
totic cardiomyocytes, we observed a higher efficiency of M2c to
phagocyte apoptotic cells compared with M1 and M2a macrophages
(Figure 5J and K ), as previously reported.22 The efferocytosis cap-
acity of M2a was increased after incubation with neutrophil super-
natant or NGAL, which is in agreement with the up-regulation of
phagocytosis receptor MertK expression (Figure 5A and B). To
test the hypothesis that neutrophil depletion leads to a defect of dy-
ing cardiomyocyte clearance in neutrophil-depleted infarcts, we
performed histological analysis and found an accumulation of apop-
totic cells in infarcts of mice treated with depleting antibody
(Figure 5L and M).
Neutrophil depletion affects macrophage
MertK expression after ischaemia
reperfusion
Finally, to verify whether the effect of neutrophils in regulating
MertK expression is also detectable in reperfused hearts, we sub-
jected mice to transient ischaemia and reperfusion. The flow cyto-
metric analysis confirmed a strong reduction of cardiac neutrophil
counts in Ly6G-treated mice. Similar to the effect after permanent
ligation, reperfused hearts of neutrophil-depleted mice had less
Ly6Chi monocytes 3 days post-infarction, but the number of macro-
phages was not significantly changed (Figure 6A and B). The latter ef-
fect might be explained by a reduction of infarct size (28+5%) that
we observed after neutrophil depletion in the reperfusion model
(data not shown). Strikingly, the number of MertKhi expressing
macrophages was significantly lower in neutrophil-depleted reper-
fused hearts (Figure 6C), which was confirmed by western blot ana-
lysis in heart lysates (Figure 6D and E).
Discussion
Acute MI leads to death of a large number of cardiomyocytes, which
induces an inflammatory process in order to remove the damaged
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tissue. In acute inflammation, neutrophils are not only vital for clear-
ing the wound from pathogens or debris but also for the resolution
of inflammation and return to tissue homeostasis.9 In the context of
MI, however, neutrophils are generally considered detrimental.
They are recruited few hours after onset of MI and contribute to
acute tissue injury, whereas their role in infarct healing has been
largely neglected so far. Here, we provide evidence that neutrophils
are required for resolving post-MI inflammation and cardiac healing.
We show that neutrophil-depleted mice subjected to MI had wor-
sened cardiac function, increased fibrosis, and a progressive increase
in biomarkers associated with HF. This was accompanied by reduced
cardiac expression of phagocytosis receptor MertK by macrophages
and a worsened capacity to clear apoptotic cardiomyocytes.
The clearance of dead cardiomyocytes and inflammatory neutro-
phils is orchestrated by macrophages which are thought to derive
from recruited Ly6Chi monocytes.3,4 After an acute inflammatory
phase mainly driven by pro-inflammatory macrophages, these cells
are replaced by reparative macrophages which facilitate wound
healing and regeneration by promoting myofibroblast accumulation,
collagen deposition, and angiogenesis. Wan and co-workers convin-
cingly demonstrated that accurate clearance of dead cells is a pre-
requisite for favourable MI healing, whereas failed resolution
promotes unfavourable cardiac remodelling which may ultimately
result in HF.5,24 In agreement with this study, our data suggest
that inefficient removal of dead cells due to impaired macrophage
phenotypic shift in the absence of neutrophil secretome leads to a
dysregulated healing response, excessive fibrosis, and progressive
loss of ventricular function.
While sufficient myofibroblast density is important for replacing
dead cardiac muscle by a robust scar, excessive myofibroblast num-
bers or inappropriate composition of collagen fibres in the infarcted
ventricle might lead to myocardial stiffness,25 contractile dysfunc-
tion, and progression of HF.26 – 28 In support of the hypothesis
that neutrophil depletion may lead to HF, we found an up-regulation
Figure 5 Neutrophils regulate macrophage polarization and efferocytosis. (A and B) Detection of MertK and GAPDH by western blot in murine
bone marrow-derived macrophages. Upper blot: bone marrow-derived macrophages were polarized with IFN-g (M1), IL-4 (M2a), or dexametha-
sone (M2c) alone or in the presence of neutrophil supernatant or recombinant murine neutrophil gelatinase-associated lipocalin (100 ng/mL).
Lower blot: bone marrow-derived macrophages were polarized in the presence of neutrophil supernatant immunoprecipitated with anti-IgG
or anti-neutrophil gelatinase-associated lipocalin. (B) Quantification of MertK band density, normalized to GAPDH, shown as arbitrary units.
(C and D) Detection of MertK and GAPDH in polarized human macrophages incubated with human neutrophil supernatant (n ¼ 2 donors).
(E and F) Detection of MertK and GAPDH by western blot in hearts of isotype-treated, neutrophil-depleted (Ly6G), or Ly6G-treated mice co-
injected with neutrophil gelatinase-associated lipocalin, 7 days after myocardial infarction. (F) Quantification of MertK band density, normalized to
GAPDH and shown as relative expression compared with isotype. (G) Plasma levels of neutrophil gelatinase-associated lipocalin at baseline or
after myocardial infarction. (H and I ) Flow cytometric quantification of M2c (MertKhi) and M2a macrophages (MertKlo) in hearts of isotype-, Ly6G-,
or Ly6G-treated mice co-injected with neutrophil gelatinase-associated lipocalin 5 days after myocardial infarction. (J and K ) Efferocytosis of
fluorescence-labelled apoptotic cardiomyocytes was measured by flow cytometry, after co-incubation of apoptotic cardiomyocytes with polar-
ized bone marrow-derived macrophages. Polarization was performed in the presence or absence of neutrophil supernatant or recombinant
mouse neutrophil gelatinase-associated lipocalin (100 ng/mL). (L) Representative TUNEL staining in infarcts of isotype or Ly6G-treated mice,
7 days after myocardial infarction. Scale bar, 200 mm; ×5 magnification. (M ) Quantification of TUNEL-positive apoptotic cells per field of
view. Data are mean+ SD from (B, F, I, and K) three experiments and donor mice, (G) 8, or (M ) 5 mice/group.
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of cardiac and systemic markers associated with HF.14,29
Cardio-renal syndrome may occur as a result of cardiac dysfunction
and hypoperfusion of the kidney leading to medullary ischaemia.30
Indeed, we detected signs of acute kidney injury, which by itself is
a prognostic factor associated with adverse outcome.16
We identified NGAL in the neutrophil secretome as a key in-
ducer of macrophages with high efferocytosis capacity. Neutrophil
gelatinase-associated lipocalin is released by activated neutrophils
from specific granules, but also from other cells including macro-
phages, ischaemic cardiomyocytes, or injured kidney epithelial cells
in acute renal injury.31 –33 In the setting of Streptococcus pneumonia
infection, it was recently shown that NGAL skewed activated alveo-
lar macrophages to a resolving phenotype expressing high levels of
IL-10.34 In skeletal muscle injury, the macrophages involved in mus-
cle regeneration have been characterized as M2c macrophages that
exhibit anti-inflammatory properties by releasing TGF-b and by
neutralizing pro-inflammatory M1 macrophages.35 In post-MI repair,
M2c marker MertK-expressing macrophages play a crucial role in
the clearance of cell debris.5
Our findings that neutrophils could contribute to improve cardiac
healing and the outcome by influencing macrophage polarization are
somewhat surprising, given that they are generally considered to
play a detrimental role after post-MI revascularization. In fact, ele-
vated circulating neutrophil counts or plasma levels of their released
factors, including NGAL, are associated with poor prognosis and
mortality in MI patients.7,36 We may speculate that a certain number
of neutrophils and secretion products are required in the local
cardiac microenvironment to promote reparative macrophage
polarization. However, there might be a threshold level where
the acute tissue damaging effects of neutrophils outweigh their
resolving properties during MI healing. This is supported by clinical
data reporting that associations between blood neutrophil counts
and clinical outcomes are mainly evident in patients with neutro-
philia (neutrophil counts . 65%)37 or in the highest tertile,38,39
respectively.
Our study has several limitations: First, the mouse model of per-
manent LAD occlusion, although widely used to study post-MI re-
pair and remodelling, may have limited predictive value for human
pathophysiology. Nevertheless, it is a valuable tool to dissect the
function of, e.g. specific-cell populations and molecular pathways in-
volved in post-MI healing, which provides the basis for more defined
therapeutic approaches. In view of potential relevance for humans, it
is promising that we could confirm the effect of neutrophil depletion
on macrophage MertK expression in the ischaemia-reperfusion
model, and we were also able to show the polarizing effect of human
neutrophil secretome in human primary macrophages. In the future,
additional studies with clinically more relevant large animal models
are warranted before extrapolating a potential significance of our
findings for humans. Second, we cannot exclude that additional fac-
tors other than NGAL might contribute to the polarizing effects of
the neutrophil secretome on macrophages. Nevertheless, we iden-
tified NGAL as a key regulator of macrophage reprogramming both
in vitro and in vivo. Finally, it is conceivable that neutrophil-derived
factors might promote autocrine release of factors by the macro-
phages themselves that might facilitate their own phenotypic
switch.34 In the future, a better knowledge of the molecular regula-
tors involved in macrophage reprogramming will help to answer
these unresolved questions.
In conclusion, our data suggest that neutrophils participate in MI
repair in a mouse model through the secretion of NGAL, thereby
skewing macrophages towards a resolving phenotype which med-
iates efficient clearance of cell debris. This is a prerequisite for regu-
lated fibrosis, scar formation and favourable cardiac remodelling.5
Our findings therefore have important clinical implications. Beyond
their established pro-inflammatory role in acute post-MI injury, we
identify neutrophils as pivotal modulators of the healing response
after MI and consequently cardiac repair and function. This novel
role for neutrophils should be taken in account when designing
and applying ‘aggressive’ anti-neutrophil treatments in the setting
of MI.
Figure 6 Neutrophil depletion modulates cardiac monocyte/macrophage profiles and MertK expression in reperfused hearts. (A–C) Repre-
sentative flow cytometry results and quantification of neutrophils, Ly6Chi monocytes and macrophages, as well as MertKhi and MertKlo macro-
phages in digested hearts of neutrophil-depleted (Ly6G) or isotype-treated mice 3 days after reperfusion. (D and E) Detection of cardiac MertK
and GAPDH by western blot, 3 days after reperfusion. Data are mean+ SD from 5 mice/group.
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